Department of Mechanical Engineering , University of Colorado , Boulder , Colorado 80309 , United States.
Bioconjug Chem. 2018 May 16;29(5):1534-1543. doi: 10.1021/acs.bioconjchem.8b00084. Epub 2018 Apr 11.
Interest in the use of targeted microbubbles for ultrasound molecular imaging (USMI) has been growing in recent years as a safe and efficacious means of diagnosing tumor angiogenesis and assessing response to therapy. Of particular interest are cloaked microbubbles, which improve specificity by concealing the ligand from blood components until they reach the target vasculature, where the ligand can be transiently revealed for firm receptor-binding by ultrasound acoustic radiation force pulses. Herein, a bio-orthogonal "click" conjugation chemistry is introduced to decorate the surface of cloaked 4-5-μm-diameter microbubbles as part of a sterile and reproducible production process. Azido-functionalized antagonists for the angiogenic biomarkers αβ integrin (cRGD) and VEGFR2 (A7R) proteins were conjugated to bimodal-brush microbubbles via strain-promoted [3 + 2] azide-alkyne cycloaddition (SPAAC) click chemistry. Ligand conjugation was validated by epifluorescent microscopy, flow cytometry, and Fourier-transform infrared spectroscopy. Sterility was validated by bacterial culture and endotoxin analysis. Additionally, clinically normal dogs receiving escalating microbubble doses were shown to experience no pathologic changes in physical examination, complete blood count, serum biochemistry profile, or coagulation panel. This bio-orthogonal microbubble conjugation process for cloaked peptide ligands may be leveraged for future USMI studies of tumor angiogenesis for translation to preclinical and clinical applications.
近年来,人们对靶向微泡在超声分子成像(USMI)中的应用越来越感兴趣,因为它是一种安全有效的诊断肿瘤血管生成和评估治疗反应的方法。特别引人关注的是伪装微泡,它通过在到达靶血管之前将配体隐藏在血液成分中,从而提高了特异性,在靶血管中,配体可以通过超声声辐射力脉冲短暂地暴露出来,与受体进行牢固结合。在此,介绍了一种生物正交的“点击”偶联化学方法,用于修饰伪装的 4-5μm 直径微泡的表面,作为无菌且可重复的生产过程的一部分。将叠氮功能化的血管生成生物标志物 αβ 整合素(cRGD)和 VEGFR2(A7R)蛋白的拮抗剂通过应变促进的[3+2]叠氮-炔环加成(SPAAC)点击化学偶联到双模态刷状微泡上。通过荧光显微镜、流式细胞术和傅里叶变换红外光谱验证了配体的偶联。通过细菌培养和内毒素分析验证了无菌性。此外,接受递增微泡剂量的临床正常犬在体检、全血细胞计数、血清生化谱或凝血面板方面均未出现病理变化。这种用于伪装肽配体的生物正交微泡偶联工艺可用于未来肿瘤血管生成的 USMI 研究,以转化为临床前和临床应用。